Compression Works
Newsroom

North Texas Angel Network, First Avenue Ventures, Atlanta Tech Angels, and Rockies Venture Club have increased their positions.

BIRMINGHAM, ALABAMA, UNITED STATES, July 23, 2024 /EINPresswire.com/ -- Compression Works, Inc., www.compressionworks.com, maker of the life-saving abdominal aortic and junctional tourniquet (the AAJT), is pleased to report increased positions from existing investors in the company’s seed round.

The AAJT was initially designed to stop severe bleeding on the battlefield so that casualties could be stabilized and evacuated to awaiting surgical teams. The utilization of this device is now rapidly expanding into the first responder community, where bleeding is the #1 cause of death in ages 6 to 49 due to automobile accidents, blunt force trauma, penetrating trauma, and pelvic bleeding, which can be difficult to detect at the scene of an accident.

Additionally, Compression Works reports treatment success in new areas of traumatic cardiac arrest and non-compressible torso hemorrhage, which will dramatically increase the market application of this device.

Existing investors who have increased their investments include North Texas Angel Network, First Avenue Ventures, Atlanta Tech Angels, and Rockies Venture Club.

“We are excited at the growth trajectory and potential of Compression Works,” said Jeff Murphy, Executive Director at North Texas Angel Network. “The NTAN Team has seen the life-saving capabilities of the AAJT in the U.S. First Responder market and on the battlefields of Ukraine, where lives are being saved. NTAN is excited to support the scale-up and growth of Compression Works, and we want to continue to play a role in reducing preventable deaths by stopping bleeding at the point of injury,” said Murphy.

Mike Goodrich, Managing Director of First Avenue Ventures in Birmingham, AL, stated, “We are thrilled to participate again in this round in a significantly de-risked opportunity. Our confidence in management has only increased since our initial early position. In a challenging capital environment, having a company that continues to take risk off the table and hit their targets and milestones gives us comfort in increasing our position,” said Goodrich.

“Compression Works has a terrific group of active investors that are adding real value in helping us scale our operation around the world,” said Scott Dodson, President and CEO of the Company. “We are now commercial in over 23 countries outside of the U.S. and have started to realize multiple EMS agency conversions in the U.S. First Responder market," said Dodson. “As the delivery of whole blood to accident victims increases across the U.S., Compression Works is playing a vital role in the prevention of blood loss so that the tank can be refilled. We expect this trend to continue as at-the-scene treatment dramatically increases survivability for accident victims.”

The company anticipates closing this round, which is already oversubscribed and encourages interested accredited investors to contact Mr. Dodson, the CEO, at This email address is being protected from spambots. You need JavaScript enabled to view it..

Article : https://www.alabamabusinessreporter.com/

Step into the vanguard of battlefield medicine with Dr. John M. Croushorn, an engineer-turned-emergency physician whose innovations are redefining trauma treatment. From his pivotal career switch of joining Army Medicine post-9/11 to creating the Abdominal Aortic Junctional Tourniquet (AAJT-S), this episode weaves together the personal and the technical, providing an intimate look at the challenges and triumphs of military medicine.

As we converse with Dr. Croushorn, you'll be transported to the front lines of tactical emergency medical solutions, where the origins of such practices in the military and law enforcement laid the groundwork for today's life-saving techniques. Discover the birth of the AAJT-S, spurred by tragedy and necessity, and how a chance encounter with a Special Forces Medic brought the device's development full circle. This narrative captures the essence of innovation - where creativity meets critical needs, and every step in the design process can mean the difference between life and death. The trenches of tactical medicine are filled with stories of lives saved and legacies forged, and each tale tightens the bond between trauma care advancements and those who stand ready at the front lines.

Dr. Croushorn continues to pull back the curtain on the dynamic field of military medicine, guiding us through the application of junctional tourniquets and their profound impact on saving lives in pre-hospital scenarios. We'll also cast an eye to the future, examining ongoing research and the global implications of these medical advancements. Hear tales of the AAJT-S's deployment in diverse environments, from the deserts of the Middle East to the conflict in Ukraine, and learn how this technology is not just a tool but a testament to human resilience and the relentless pursuit of advancing trauma treatment.

Take Home Messages:
1. The tragic events of 9/11 inspired a shift in career from electrical engineering to Military Medicine, highlighting the profound impact significant historical events can have on individual life choices.
   
2. The development of the Abdominal Aortic Junctional Tourniquet (AAJT-S) marked a significant advancement in pre-hospital trauma care, particularly for severe hemorrhage control in areas where traditional tourniquets are ineffective.

3. Innovation in military medical devices can stem from unexpected places, including the adaptation of materials like bike shop inner tubes, demonstrating resourcefulness in the face of challenges.

4. Collaboration between medical professionals and those with hands-on battlefield experience, such as Special Forces Medics, is crucial for the practical development of life-saving medical technologies.

5. Tactical emergency medical solutions, like the AAJT-S, have evolved to meet the specific needs of military and emergency response situations, including combat scenarios and disaster relief efforts.

6. The versatility of junctional tourniquets makes them a critical tool not only for the military but also for civilian emergency services, as evidenced by their use by air ambulance services and fire departments.

7. Emergency Medicine is continually advancing, with a focus on developing solutions for non-compressible torso hemorrhage, which presents new challenges in the field of trauma care.

8. Groundbreaking research into the physiologic effects of medical devices in traumatic cardiac arrest scenarios is paving the way for updated emergency protocols and potentially higher survival rates.

9. The global impact of military medical innovations can be seen in various international settings, including conflict zones like Ukraine, where they play a vital role in saving lives on the battlefield.

10. Effective hemorrhage control, particularly in junctional areas, is essential for improving survival rates in trauma patients, emphasizing the importance of continuous innovation and application of medical devices in pre-hospital settings. 

Background: 'Non-compressible' haemorrhage is the leading cause of preventable battlefield death, often requiring surgical or radiological intervention, which is precluded in the pre-hospital environment. One-fifth of such bleeds are junctional and therefore potentially survivable.